Long-Term Follow-Up Results of Alpha Interferon Therapy in Chronic Myelogenous Leukemia at M. D. Anderson Cancer Center
- 1 January 1993
- journal article
- clinical trial
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 11 (sup1) , 169-174
- https://doi.org/10.3109/10428199309047881
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.Journal of Clinical Oncology, 1992
- A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemiaCancer, 1991
- Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of philadelphia chromosome-negative cells in chronic myelogenous leukemiaCancer, 1991
- Clinical investigation of human alpha interferon in chronic myelogenous leukemiaBlood, 1987
- Preferential inhibition by cytarabine of CFU-GM from patients with chronic granulocytic leukemiaCancer, 1987
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986